News Releases

LAGUNA HILLS, Calif. --(BUSINESS WIRE)--Nov. 16, 2026-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the third quarter ended September
November 16, 2026
Enrollment Underway Across Multiple Sites as Study Advances Faster, Improved ULTA Catheter for the Broadest Population of VT Patients LAGUNA HILLS, Calif. --(BUSINESS WIRE)--Sep. 16, 2026-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter
September 16, 2026
LAGUNA HILLS, Calif. --(BUSINESS WIRE)--Aug. 11, 2026-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30,
August 11, 2026